Insights for the future of wellness care.

Physician-led perspectives on emerging therapies, healthcare compliance, telehealth, and AI in healthcare, from the team at Arora Health.

Clinical Programs
October 22, 2026

New Menopause Guidelines Expand Hormone Therapy Treatment Options for Women's Health

ACOG’s updated menopause guidelines highlight evolving treatment options and a more personalized approach to women’s health.

Press
September 30, 2026

Fitt Insider: Arora Health Launches Women's Health Study

Arora Health announces a physician-led perimenopause study in Fitt Insider, advancing real-world research on women's hormone health and personalized care.

Press
September 28, 2026

MedWorld News: Building Better Digital Health Through Clinical Innovation

Dr. Sean Arora shares insights with MedWorld News on digital health innovation, AI, physician oversight, and building scalable clinical infrastructure.

Press
September 21, 2026

Medscape: How Nanomedicine Could Transform Obesity Treatment

Dr. Sean Arora shares insights in Medscape on nanomedicine, obesity treatment, metabolic health, and why patient outcomes go beyond weight loss.

Press
September 17, 2026

MDLinx: The Role of Bloodwork in Peptide Therapy

Dr. Sean Arora shares insights with MDLinx on peptide therapy, targeted bloodwork, patient evaluations, and the importance of clinical oversight.

Press
September 8, 2026

Inc.: How GLP-1 Medications Are Changing Fast-Food Habits

Dr. Sean Arora shares insights with Inc. on how GLP-1 medications are changing eating habits, fast-food portions, and nutritional needs during weight loss.

Press
September 3, 2026

Authority Magazine: Dr. Shannon Arora on Building Safer Wellness Clinics

Dr. Shannon Arora shares insights in Authority Magazine on physician oversight, healthcare compliance, hormone therapy, and safer wellness clinic growth.

Press
August 27, 2026

Authority Magazine: 5 Best Practices for Safer Telehealth Care

Dr. Sean Arora shares five telehealth best practices in Authority Magazine, covering clinical oversight, patient safety, compliance, and scalable care. Copy

Clinical Programs
August 26, 2026

Supporting Your Patients Through Perimenopause and Menopause: Nutrition, Hormones, and a Whole-Person Approach

Explore five foods healthcare providers can recommend during perimenopause and menopause, plus strategies to support hormonal, metabolic, bone, and overall health.

Compliance
August 2, 2026

Peptides at a Regulatory Crossroads: What 503A Pharmacies Need to Know After the July 2026 FDA Meeting

The FDA's July 2026 peptide meeting raised important questions for 503A pharmacies. Here's what the recommendations mean for compliance and patient care.

Press
July 28, 2026

MedEsthetics: What It Actually Takes to Scale a Telehealth Program

Sean Arora, MD, shares expert insights in MedEsthetics magazine on scaling telehealth without compromising quality, compliance, physician oversight, or patient care.

Press
July 23, 2026

Healthcare Business Today: The Future of Wellness Clinics Depends on Compliance

Healthcare Business Today featured Arora Health's insights on why compliance, physician oversight, and operational infrastructure are essential for sustainable growth.

Press
July 23, 2026

Forbes Health: The Cost and Considerations of GLP-1 Microdosing

Explore Dr. Sean Arora's insights in Forbes Health on GLP-1 microdosing costs, insurance coverage, personalized dosing, and patient safety.

Compliance
July 15, 2026

Protecting Your Practice: What Aesthetic and Wellness Providers Need to Know About Website Tracking and Patient Privacy

Tracking pixels on your med spa website could create serious legal risk. Learn how privacy laws apply and the steps to better protect your practice.

Industry Trends
July 1, 2026

Longevity Medicine's Promise Belongs to Everyone

Longevity medicine has the potential to improve healthspan for everyone, not just those with privileged access. Explore why equity, prevention, and broader access should shape the future of healthy aging.

Industry Trends
May 13, 2026

The PCOS to PMOS Name Change and the Future of Women’s Health

The shift from PCOS to PMOS is more than a name change. It reflects a larger movement toward personalized, preventative, and metabolically focused healthcare for women. In our latest blog, we break down what’s changing in women’s health and where the industry is headed next.

Clinical Programs
March 2, 2026

Medical Director’s Guide to Oral Semaglutide for GLP-1 Clinics

Considering oral semaglutide in your clinic? A medical director explains efficacy, business risk, compounded tirzepatide, and regulatory considerations.

Clinical Programs
February 28, 2026

The "Wegovy Pill": Oral GLP-1 vs Injection for Weight Loss

Can you skip the GLP-1 injection? Medical Director Dr. Alex Saucedo compares oral semaglutide vs injectable GLP-1 for weight loss, results, and side effects.

Arora News
February 26, 2026

The Regulatory Transition of New Jersey Clinical Practice: A Formal Analysis of Executive and Legislative Mandates

A formal analysis of New Jersey’s post-pandemic regulatory reset, including Executive Orders 415 and 13, the April 2, 2026 compliance deadline, and Senate Bill S2996.

Clinical Programs
February 18, 2026

Sexual Health is Health Care: Why Breaking the Stigma Matters for Providers and Patients

Sexual health is foundational to overall wellness. Learn why providers must address stigma and deliver evidence-based, responsible care for patients.

Practice Growth
January 6, 2026

January GLP-1 Readiness Checklist for Clinics

Scaling GLP-1 programs isn’t about volume — it’s about readiness. Our physician-led GLP-1 Readiness Checklist shares the operational and clinical areas clinics should review before seasonal demand peaks.

Clinical Programs
January 1, 2026

GLP-1 Membership Models After the FDA Shortage: What’s Still Compliant and What’s Not

The removal of GLP-1s from the FDA shortage list fundamentally changed how these therapies may be prescribed, dispensed, and billed. Models that were once tolerated now carry meaningful regulatory risk.

Industry Trends
December 17, 2025

Women’s Longevity is Being Quietly Under-Dosed

Women deserve longevity strategies that are as intentional, data-guided, and proactive as those routinely offered to men. When women’s longevity is under-dosed, the limitation is not the therapy. It is the reluctance to apply it correctly.

Clinical Programs
December 14, 2025

Why Peptides Are Taking Over Modern Medicine

Peptides are emerging as one of the most impactful tools in preventative and regenerative medicine. These targeted amino-acid chains support metabolism, cellular repair, immune function, recovery, and overall vitality, making them a natural fit for aesthetics, longevity, and wellness programs.

Clinical Programs
November 30, 2025

The GHK-Cu Peptide: Benefits, Uses, and Why it’s Known as the Regenerative Copper Complex

GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring peptide that helps your skin and hair repair and renew themselves. Our bodies make less of it as we age, which can lead to slower healing, thinning hair, and loss of firmness or glow in the skin.

Arora News
November 23, 2025

Arora Launches Physician-Led Platform for Longevity, Wellness, and Medspa Growth

Arora Health & Aesthetics announced the national rollout of its physician-led operating platform designed for wellness and telehealth companies. Founded by Dr. Sean Arora, the company integrates national medical oversight, 50-state regulatory guidance, and telehealth infrastructure into one cohesive system so companies can scale responsibly.